Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564381 · ClinicalTrials.gov registry record · Phase 1
Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT01564381 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 64 participants.
The verdict
NCT01564381, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
The investigators hope to learn if resveratrol supplementation can be beneficial for the cardiovascular system. Seeing that resveratrol is rapidly metabolized, the investigators are interested in learning if a novel form of resveratrol, ResA, which is a mixture of resveratrol with amino acid, may have greater bioavailability and lead to greater improvement in vascular function, compared to standard resveratrol supplement.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Resveratrol
- DIETARY_SUPPLEMENT ResA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01564381
The ClinicalTrials.gov registry entry for NCT01564381 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01564381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01564381 about?
NCT01564381 is a clinical study titled "Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women". The investigators hope to learn if resveratrol supplementation can be beneficial for the cardiovascular system. Seeing that resveratrol is rapidly metabolized, the investigators are interested in learning if a novel form of resveratrol, ResA, which is a mixture of resveratrol with amino acid, may ha...
What is the current status of trial NCT01564381?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2012-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01564381?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Resveratrol (DIETARY_SUPPLEMENT), ResA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01564381?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.